Health ❯ Healthcare

Diabetes

Type 2 Diabetes Type 1 Diabetes Diabetes Management Insulin Complications Medications Treatment Options Management Treatment Insulin Treatment Insulin Therapy Hypoglycemia Weight Loss Clinical Trials Monitoring Devices Diabetes Medications Obesity GLP-1 Medications Technology Diabetic Retinopathy Monitoring Type 2 Diabetes Mellitus Patient Education Blood Sugar Control Space Medicine Diabetes Prevention Diabetic Complications Insulin Pumps AI in Healthcare Diabetes Treatment Type 2 Diabetes Treatments Pharmaceutical Research Side Effects Type 2 Diabetes Management School Health Insulin Delivery Systems Diabetes Screening Blood Sugar Monitoring Weight Management Continuous Glucose Monitoring Prevention Research Symptoms Diabetes Mellitus Screening Tests Chronic Kidney Disease Insulin Delivery Medication Drug Development Patient Care Insulin Administration Patient Management Diabetic Foot Care Medical Conditions Screening Autoimmune Diseases Insulin Types Chronic Conditions Treatment Innovations Adolescent Health Type 2 diabetes Diabetes Treatments HbA1c Management Hormonal Influence Management Strategies Treatment Strategies Treatment Methods Software Issues Insulin Access Glucose Monitoring GLP-1 Agonists Type 1 and Type 2 Diabetes Anti-Diabetic Drugs GLP-1 Receptor Agonists Prediabetes

FDA Seeks Removal of Suicide Warnings From Saxenda, Wegovy and Zepbound

The move follows FDA analyses of 91 trials plus a 2.24 million‑patient claims study that found no increased risk.

Amgen Reports Year-Long Weight-Loss Maintenance With Monthly or Quarterly MariTide Dosing

Oxford Review Finds GLP-1 Weight Loss Largely Lost Within About Two Years After Stopping

ViCentra Adds $13 Million to Series D, Lifting Kaleido Funding to $98 Million

Abbott Launches Libre Assist in FreeStyle Libre App to Predict Meal Glucose Impact

CHMP Backs Expanded EU Use of Mounjaro for Diabetes in Patients 10+ and Adult Weight Management

Meta-Analysis Finds GLP-1 Drugs Show Little Short-Term Impact on Obesity-Linked Cancer Risk

Stopping GLP-1 Weight-Loss Drugs Before Pregnancy Linked to Higher Gestational Risks, Study Finds

Lancet Phase 3 Trial Shows Oral GLP-1 Orforglipron Aids Weight Loss and Diabetes Control

Polymer Lets Insulin Cross Skin in Animals, Matching Injections in Early Tests

EU Medicines Panel Backs Teizeild to Delay Type 1 Diabetes Onset

JAMA Meta-Analyses at Kidney Week Back Routine SGLT2 Inhibitors Across Kidney Function

Lilly to Launch Late-Stage Trials of Amylin Obesity Drug After 20% Weight Loss in Mid-Stage Study

AI App Matches Human-Led Diabetes Prevention in Phase 3 Trial

Lilly’s Oral GLP-1 Orforglipron Beats Farxiga and Placebo in Two Phase 3 Diabetes Trials

Neil Diamond Receives Carousel Ball Honor, Delivers Rare Sweet Caroline Duet

Biomea Fusion Prices Equity Offering With Warrants to Raise About $25 Million

Costco to Offer Ozempic and Wegovy for $499 a Month to Self-Pay Members Nationwide

Study Finds CGMs Track HbA1c in Type 2 Diabetes but Not in People Without Diabetes

Arecor and Sequel to Co-Develop AT278 With Twiist AID for High-Dose Diabetes Care